Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2
Bulos, M. L.; Grzelak, E. M.; Li-Ma, C.; Chen, E.; Hull, M.; Johnson, K. A.; Bollong, M. J.
Show abstract
Yes-associated protein (YAP), the downstream effector of the evolutionarily conserved Hippo pathway, promotes cellular proliferation and coordinates certain regenerative responses in mammals. Small molecule activators of YAP may therefore display therapeutic utility in treating disease states involving insufficient proliferative repair. From a high-throughput chemical screen of the comprehensive drug repurposing library ReFRAME, here we report the identification of SM04690, a clinical stage inhibitor of CLK2, as a potent activator of YAP driven transcriptional activity in cells. CLK2 inhibition promotes alternative splicing of the Hippo pathway protein AMOTL2, producing an exon-skipped gene product that can no longer associate with membrane-bound proteins, resulting in decreased phosphorylation and membrane localization of YAP. This study reveals a novel mechanism by which pharmacological perturbation of alternative splicing inactivates the Hippo pathway and promotes YAP dependent cellular growth.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Small-molecule inhibition of Lats kinases promotes Yap-dependent proliferation in postmitotic mammalian tissues 97%
- The Endo-GeneScreen Platform Identifies Drug-Like Probes that Regulate Endogenous Protein Levels within Physiological Contexts 96%
- RAF inhibitors activate the integrated stress response by direct activation of GCN2 95%
Similar papers in this journal
Similar papers in this journal
- The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis 95%
- A Non-genetic Mechanism for Chemoresistance in Lung Cancer: The Role of Integrin β4/Paxillin Axis 94%
- Loss of PI3-kinase activity of inositol polyphosphate multikinase impairs PDK1-mediated AKT activation, cell migration, and intestinal homeostasis 94%
Similar papers in this journal
- A drug's most potent target is not necessarily the source of its anti-cancer activity 95%
- Targeting the PI5P4K lipid kinase family in cancer using novel covalent inhibitors 95%
- A direct high-throughput protein quantification strategy facilitates discovery and characterization of a celastrol-derived BRD4 degrader 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.